Srs Capital Advisors, Inc. Xencor Inc Transaction History
Srs Capital Advisors, Inc.
- $1.5 Billion
- Q4 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Xencor Inc stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 485 shares of XNCR stock, worth $7,866. This represents 0.0% of its overall portfolio holdings.
Number of Shares
485
Previous 407
19.16%
Holding current value
$7,866
Previous $8,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding XNCR
# of Institutions
198Shares Held
73.7MCall Options Held
1.7KPut Options Held
4.2K-
Black Rock Inc. New York, NY11.1MShares$180 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.98MShares$146 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.02MShares$130 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$99.7 Million6.6% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.04MShares$65.5 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $968M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...